Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study

Author: Hołowiecki Jerzy   Grosicki Sebastian   Kyrcz-Krzemien Sławomira   Skotnicki Aleksander   Piatkowska-Jakubas Beata   Warzocha Krzysztof   Seferynska Ilona   Zdziarska Barbara  

Publisher: Springer Publishing Company

ISSN: 0939-5555

Source: Annals of Hematology, Vol.87, Iss.5, 2008-05, pp. : 361-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content